63449-37-6

Basic information

• Product Name: ETHYL 4-[(2-ETHOXY-2-OXOETHYL)THIO]BUTANOATE
• Synonyms: BUTTPARK 94\04-65;ETHYL 4-[(2-ETHOXY-2-OXOETHYL)THIO]BUTANOATE;ETHYL 4-(ETHOXYCARBONYLMETHYLTHIO)BUTYRATE;Ethyl 4-[(2-ethoxy-2-oxoethyl)sulphanyl]butanoate, Ethyl 4-[(2-ethoxy-2-oxoethyl)thio]butyrate;Butanoic acid, 4-[(2-ethoxy-2-oxoethyl)thio]-,ethyl ester
• CAS NO: 63449-37-6
• Molecular Formula: C₁₀H₁₈O₄S
• Molecular Weight: 234.31
• Mol File: 63449-37-6.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 311.3°C at 760 mmHg
• Flash Point: 138.1°C
• Appearance: /
• Density: 1.092g/cm³
• Vapor Pressure: 0.000567mmHg at 25°C
• Refractive Index: 1.47
• CAS DataBase Reference: ETHYL 4-[(2-ETHOXY-2-OXOETHYL)THIO]BUTANOATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4-[(2-ETHOXY-2-OXOETHYL)THIO]BUTANOATE(63449-37-6)
• EPA Substance Registry System: ETHYL 4-[(2-ETHOXY-2-OXOETHYL)THIO]BUTANOATE(63449-37-6)

Safety Data

• Safety Statements: S24/25:Avoid contact with skin and eyes.
• Hazardous Substances Data: 63449-37-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C10H18O4S/c1-3-13-9(11)6-5-7-15-8-10(12)14-4-2/h3-8H2,1-2H3

Upstream product

• 3153-36-4 4-chloro-butyric acid ethyl ester 
• 141-52-6 sodium ethanolate 
• 623-51-8 ethyl 2-sulfanylacetate 
• 2969-81-5 Ethyl 4-bromobutyrate 

Downstream Products

• 58509-73-2 ethyl 3-oxothiane-2-carboxylate 
• 135369-32-3 ethyl 3-oxotetrahydro-2H-thiopyran-4-carboxylate 
• 19090-03-0 dihydro-2H-thiopyran-3(4H)-one 
• 1450790-46-1 2-(4-(trifluoromethyl)phenyl)-7,8-dihydro-3H-thiopyrano[3,2-d]pyrimidin-4(6H)-one 
• 1429638-98-1 (S)-1-cyclopropyl-3-(4-(4-(3-methylmorpholino)-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidin-2-yl)phenyl)urea 
• 87466-23-7 2,4-dichloro-7,8-dihydro-6H-thiopyrano<3,2-d>pyrimidine 
• 76943-07-2 tetrahydro-2H-thiopyran-3-amine 1,1-dioxide hydrochloride 
• 117593-38-1 3-aminothiacyclohexane 
• 1233704-64-7 N-ethyl-6-(3-oxo-3,5,6,7-tetrahydrothiopyrano[3,2-c]pyrazol-2(1H)-yl)-N-phenylpyridine-3-sulfonamide 
• 135369-52-7 10-Benzyl-7,8-dihydro-2-morpholino-9H,10H-thiopyrano<3,2-d>-1,2,4-triazolo<1,5-a>pyrimdin-5-one 
• 135369-53-8 10-Benzyl-6,7-dihydro-2-morpholino-5H,10H-thiopyrano<2,3-e>-1,2,4-triazolo<1,5-a>pyrimidin-9-one 
• 135369-55-0 10-Benzyl-7,8-dihydro-2-benzylamino-9H,10H-thiopyrano<3,2-d>-1,2,4-triazolo<1,5-a>pyrimidin-5-one 
• 135369-51-6 10-Benzyl-7,8-dihydro-2-diethylamino-9H,10H-thiopyrano<3,2-d>-1,2,4-triazolo<1,5-a>pyrimdin-5-one 
• 135369-46-9 10-Benzyl-7,8-dihydro-2-methylthio-9H,10H-thiopyrano<3,2-d>-1,2,4-triazolo<1,5-a>pyrimidin-5-one 

Relevant articles and documents

SUBSTITUTED PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

The present invention relates to compounds according to Formula (I-1) and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

FUSED TRICYCLIC COMPOUNDS FOR USE AS INHIBITORS OF JANUS KINASES

The invention provides novel compounds of formula (I) having the general formula (I) wherein R1, V, W, X, Y and Z are as described herein. Accordingly, the compounds may be provided in pharmaceutically acceptable compositions and used for the treatment of immunological or hyperproliferative disorders.